Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam · Delayed Price · Currency is VND 84,000
-2,600 (-3.00%)
At close: Sep 8, 2025
Ha Tay Pharmaceutical JSC Revenue
Ha Tay Pharmaceutical JSC had revenue of 1.07T VND in the quarter ending June 30, 2025, with 125.72% growth. This brings the company's revenue in the last twelve months to 2.16T, up 10.49% year-over-year. In the year 2024, Ha Tay Pharmaceutical JSC had annual revenue of 2.09T with 4.35% growth.
Revenue (ttm)
2,157.26B
Revenue Growth
+10.49%
P/S Ratio
3.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
6,941.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,086.35B | 87.05B | 4.35% |
| Jan 1, 2024 | 1,999.30B | 161.91B | 8.81% |
| Dec 31, 2022 | 1,837.39B | 228.03B | 14.17% |
| Dec 31, 2021 | 1,609.36B | -397.11B | -19.79% |
| Dec 31, 2020 | 2,006.48B | -35.76B | -1.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition